|
Api-Bioxal
|
886 mg/g
|
V/MRP/21/0019
|
Chemicals Laif S.p.A., Itālija
|
QP53AG03
|
honey bees
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Powder for in-hive use
|
| International name (active substance): |
Oxalic acid dihydrate
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Chemifarma S.p.A., Itālija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 230321M+LI (23-Mar-2021)
|
| Labelling text: |
[DOCX] 230321M+LI (23-Mar-2021)
|
| Summary of product characteristics: |
[DOCX] 230321ZA (23-Mar-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/21/0019-01 |
886 mg/g |
1 |
iepakojums, 35 g |
-
|
| V/MRP/21/0019-02 |
886 mg/g |
1 |
iepakojums, 175 g |
-
|
| V/MRP/21/0019-03 |
886 mg/g |
1 |
iepakojums, 350 g |
-
|
|
|
Api-Bioxal
|
62 mg/ml
|
V/MRP/21/0021
|
Chemicals Laif S.p.A., Itālija
|
QP53AG03
|
honey bees
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
Bee-hive solution
|
| International name (active substance): |
Oxalic acid dihydrate
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Chemifarma S.p.A., Itālija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 171221M+LI (17-Dec-2021)
|
| Labelling text: |
[DOCX] 171221M+LI (17-Dec-2021)
|
| Summary of product characteristics: |
[DOCX] 171221ZA (17-Dec-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/21/0021-01 |
62 mg/ml |
1 |
ABPE pudele, 500 ml |
-
|
| V/MRP/21/0021-02 |
62 mg/ml |
1 |
ABPE konteiners, 5 l |
-
|
| V/MRP/21/0021-03 |
62 mg/ml |
1 |
Polietilēna maiss, 5 l |
-
|
|